AP NEWS

Global Radiation Dose Management Market by Product & Service, Modality, End User and Geography - Forecast to 2023: Expected to Grow at a CAGR of 39% - ResearchAndMarkets.com

October 11, 2018

DUBLIN--(BUSINESS WIRE)--Oct 11, 2018--The “Global Radiation Dose Management Market - Segmented by Products & Services, Modality, End User (Ambulatory Care Settings, Hospitals, Research Institutes and Academic Medical Centers), and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The Global Radiation Dose Management Market is expected to register a CAGR of 39% during the forecast period, 2018 to 2023.

Radiation overexposure may cause long-term health consequences. As an example, In the United States patients are exposed to excess radiation brain scans and the amount of dose received eight times higher than the normal level.Due to increasing concerns, the FDA urged imaging centers and manufacturers to comply with protocols specific to each scanning procedure. The FDA also recommends hospitals to implement dosing protocols for dose adjustment for improving patient safety during CT scans.Most hospitals and imaging centers are increasingly adopting new dose reduction technology systems with high-end CT systems. The dose tracking software reduces the burden of the manual collection of doses for CT performed in a center. This is also beneficial in the early detection of wrong dose selection.All the above factors are expected to contribute to the growth of the Radiation Dose Management market in the forecast period. The other factors such as Stringent Government Regulations and awareness and industry initiatives for radiation dose management are expected to drive the Radiation Dose Management MarketKey HighlightsIncreasing Concerns over Radiation OverexposureLow Adoption of RDM Solutions in Emerging CountriesThe US is Expected to Lead the Market in the North America Region

Major Market Developments

Bayer closes Monsanto acquisition. The acquisition of Monsanto is a strategic milestone in strengthening our portfolio of leading businesses in health and nutrition.Companies ProfiledBayer AGBracco Imaging S.P.A.Fujifilm Holdings CorporationGE HealthcareMedsquare S.A.SNovarad CorporationPACSHealth LLCPhilips HealthcareQaelum N.V.Sectra AB

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Company Profiles & Competitive Landscape

9. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/nbwnlg/global_radiation?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181011005422/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Imaging

KEYWORD:

INDUSTRY KEYWORD: HEALTH RADIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/11/2018 08:18 AM/DISC: 10/11/2018 08:18 AM

http://www.businesswire.com/news/home/20181011005422/en

AP RADIO
Update hourly